Objective: Hepatectomy for hepatolithiasis can be performed by following an open approach or a minimally invasive surgery (MIS) approach. MIS is associated with theoretical advantages, but there is no consensus regarding to the best treatment method for hepatolithiasis. The objective of this study was to evaluate the clinical outcomes of MIS hepatectomy compared with those of open hepatectomy in hepatolithiasis patients.
Methods: A systematic literature search was performed using PubMed, Embase and Cochrane Library databases. The data were analyzed with Stata version 12.0 software. Meta-regression analysis was used to explore the potential sources of heterogeneity. Egger's tests and Begg's funnel plots were employed to evaluate the publication biases.
Results: In total, 12 nonrandomized controlled trials were identified. Compared with open hepatectomy, the volume of intraoperative blood loss was significantly less in MIS hepatectomy (SMD = -0.226, P = 0.000). The intraoperative blood transfusion rate was also lower in MIS hepatectomy (RR = 0.569, P = 0.003). A shorter length of postoperative hospital stay was noted with MIS hepatectomy (SMD = -0.537, P = 0.000). MIS hepatectomy resulted in a lower rate of postoperative complications than open hepatectomy (RR = 0.595, P = 0.000). However, MIS hepatectomy resulted in a longer operation time (SMD = 0.473, P = 0.005). No significant differences were noted between MIS and open hepatectomy in the initial stone clearance rate (RR = 1.33, P = 0.218), the final stone clearance rate (RR = 1.040, P = 0.131), the stone recurrence rate (RR = 0.558, P = 0.072) or the cholangitis recurrence rate (RR = 0.610, P = 0.285).
Conclusions: MIS hepatectomy is a safe approach for hepatolithiasis patients. MIS hepatectomy significantly reduces intraoperative blood loss, blood transfusion, postoperative hospital stay time and complications. The stone clearance and recurrence rates were similar for MIS hepatectomy and open hepatectomy. Additional well-designed randomized controlled trials and Western studies are needed to confirm these findings.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijsu.2017.12.038 | DOI Listing |
HPB (Oxford)
January 2025
Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA. Electronic address:
Background: Utilization of minimally invasive surgery (MIS) has become increasingly popular due to its potential benefits such as earlier recovery and reduced morbidity. We sought to characterize differences in 1-year healthcare costs and missed workdays among patients undergoing MIS and open surgery for a hepatic or pancreatic indication.
Methods: Data on patients who underwent hepatic and pancreatic resection were obtained from the IBM Marketscan database.
J Robot Surg
November 2024
Department of Surgical Affairs, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
In the era of minimally invasive surgery (MIS), parenchyma-preserving liver resections are gaining prominence with the potential to offer improved perioperative outcomes without compromising oncological safety. The surgeon learning curve remains challenging, and simulation plays a key role in surgical training. Existing simulation models can be limited by suboptimal fidelity and high cost.
View Article and Find Full Text PDFJ Surg Oncol
October 2024
Department of Surgery, University of Western Ontario, London, Ontario, Canada.
Background: Previous studies report promising outcomes with minimally invasive (MIS) hepatectomy in elderly patients but remain limited by small size. This study aims to comparatively evaluate the demographics and outcomes of geriatric patients undergoing MIS and open hepatectomy.
Method: The 2016-2021 NSQIP database was evaluated comparing patients ≥75 undergoing MIS versus open hepatectomy.
Cancers (Basel)
June 2024
Department of Hepatopancreaticobiliary and Transplantation Surgery, Saint Vincent's University Hospital, D04 T6F4 Dublin, Ireland.
The incidence of colorectal cancer and colorectal liver metastases (CRLM) is increasing globally due to an interaction of environmental and genetic factors. A minority of patients with CRLM have surgically resectable disease, but for those who have resection as part of multimodal therapy for their disease, long-term survival has been shown. Precision surgery-the idea of careful patient selection and targeting of surgical intervention, such that treatments shown to be proven to benefit on a population level are the optimal treatment for each individual patient-is the new paradigm of care.
View Article and Find Full Text PDFSurg Endosc
August 2024
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.
Background: Although minimally invasive hepato-pancreato-biliary (MIS HPB) surgery can be performed with good outcomes, there are currently no standardized requirements for centers or surgeons who wish to implement MIS HPB surgery. The aim of this study was to create a consensus statement regarding safe dissemination and implementation of MIS HPB surgical programs.
Methods: Sixteen key questions regarding safety in MIS HPB surgery were generated after a focused literature search and iterative review by three field experts.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!